Prof. Dr. Neva Caliskan Lehrstuhl Biochemie III 93053 Regensburg Tel: +49 941 9432471 E-Mail: [email protected] ...

To study pathogenesis and develop vaccines, it would be desirable to use infectious HIV and SIV clones derived from plasma viral RNA, which is more representative of the replicating virus pool ...

HIV is a virus. Viruses are microscopic germs that are unable to multiply (replicate) by themselves. Instead, they need to find and infect a cell that will act as a host in which new viruses can be ...

Many new names sounded as if they’d been cooked up by a medieval monk. HIV-1 would henceforth be known as Lentivirus ...

During untreated HIV infection, many different variations ... the virus makes and how that protein interacts with the RNA of ...

They graphically represent the life cycle of HIV-1, from the initial binding of ... cell's nucleus to spark the formation of new viral RNA strands (Viral Gene Transfer), and finally to the ...

The global rapid RNA testing kits market, valued at approximately USD 5,890.0 Million in 2021, is set to experience impressive growth, with projections indicating a robust 6.8% CAGR, pushing the ...

Combine the virus genes with vectors ... Note: Although the genetic material of HIV is RNA, the procedure for making the vaccine is similar.

Some of the cell's RNA molecules, researchers found, help regulate antiviral signaling. These signals are part of the intricate coordination of immune responses against virus invasion. With RNA ...

HIV is a virus. It may cause AIDS after you’ve been infected for several years and it’s weakened your immune system. HIV doesn’t affect everyone the same way. Some people notice signs soon ...

Discover a study that highlights that both the 2-dose and 3-dose HepB-CpG regimens provide better seroprotection compared to ...

Guided by RNA, the Cas9 endonuclease breaks DNA at a ... Mutations of CCR5 have been linked to improved outcome to HIV infection. Here the authors use CRISPR-Cas9 genome editing of CCR5 in ...